Cardiovascular disease remains the leading cause of illness and death worldwide, claiming approximately 20 million lives every year. Perhaps one of the biggest contributors is heart valve failure, a condition where the heart can no longer regulate blood flow correctly. While repairing a damaged valve is the ideal medical option, doing so is impossible in roughly 70% of cases, making valve replacement, most commonly of the aortic (which controls blood leaving the left ventricle) or mitral valves (which controls blood entering the left ventricle), a necessity for the majority of patients. In the United States alone, over 80,000 heart valve replacements are performed annually. 

However, current replacement valves have significant drawbacks. Mechanical valves, which are artificial devices designed to replicate the function of natural valves and maintain one-way blood flow, are extremely durable, but they require patients to receive lifelong anticoagulation therapy (the use of blood thinners to prevent or treat dangerous blood clots), which increases the risk of major bleeding events 1–2% per year. This risk is taken in order to mitigate the risks of thrombosis formation (the dangerous formation of a blood clot inside a vein or artery, obstructing blood flow) and embolic strokes (a type of stroke caused by a blood clot forming, usually in the heart or neck arteries, that travels to and blocks blood flow to the brain), a consequence of the body recognizing artificial surfaces as foreign material. This is a major issue as thrombosis and bleeding together account for about 75% of postoperative issues in prosthetic valves. In contrast, biological valves, from human or animal tissue, are more biocompatible but lack durability and cannot grow with pediatric patients. Therefore, although mechanical and biological heart valves have saved millions of lives, 3D-printed and bioprinted heart valves present a transformative shift in cardiac surgery by offering patient-specific design, reduced clotting risk, and potential for growth; however, they must overcome durability and regulatory challenges before becoming the new clinical standard.

By utilizing advanced medical imaging such as CT and MRI scans, researchers can create high-resolution digital models of a patient’s heart. These models are refined using CAD software to design valves that match the patient’s exact anatomy. This approach replaces the traditional “one-size-fits-all” model, which often leads to complications such as paravalvular leaks (when implants do not perfectly fit the heart structure).

Previous prosthetic valves, whether mechanical or biological, were unable to adapt to a recipient’s physical growth. This was a major disadvantage for pediatric patients, as they had to endure several high-risk surgeries to replace outgrown valves. 3D printing currently offers a solution through the creation of tissue-engineered scaffolds seeded with a patient’s own cells. These structures can grow, repair themselves, and integrate with the patient’s natural tissue. 

Could the next generation of heart valves finally eliminate the need for lifelong anticoagulation therapy? To avoid the risk of thrombosis formation and the resulting strokes, researchers are developing implants that the immune system recognizes as “self” rather than a foreign threat. By using natural polymers, specifically bioprinted collagen or fibrin, these valves mirror the heart’s natural environment. Unlike the surfaces of synthetic plastics or metals used in mechanical heart valves, this material promotes natural blood flow. Furthermore, by incorporating the patient’s own stem cells into the 3D structure, these valves become living tissues as opposed to artificial parts. This helps ensure that the implant is not attacked by the immune system, significantly reducing the thrombosis and inflammatory responses that typically lead to valve failure.

Several prototypes are currently being developed for future 3D-printed heart valves. One example is the TRISKELION polymeric heart valve, which is primarily used as a testing prototype to study how new valve designs perform under realistic conditions. It mimics the natural three-cusp structure of the aortic valve and includes a central support structure to improve stability. Researchers create silicone versions of the valve using high-resolution 3D printing so they can quickly test factors such as closing time, blood flow, and regurgitation (the backflow of blood). Testing shows that the TRISKELION valve produces pressure gradients (the difference in blood pressure on either side of the valve as blood moves through it) similar to currently used prosthetic valves, suggesting that its blood flow resistance is within an acceptable range. If a valve creates too large of a pressure difference, it means the heart must work harder to push blood through, which can be dangerous over time. The heart muscle thickens to push against the pressure, becoming weaker over time and thus impacting its ability to fill with enough blood or pump blood out efficiently.

3D-printed heart valves present several challenges that continue to spark debate in the medical community. Because these devices must meet strict safety and effectiveness standards, they require extensive preclinical testing before receiving regulatory approval. Although this process can slow innovation, it is necessary to protect patient safety. Because many 3D-printed valves are customized for individual patients, traditional clinical trial methods may not always apply, making regulation more complex. The technology is also expensive, requiring specialized printers, materials, software, and trained personnel, which raises concerns that personalized valves may only be accessible to higher-income patients if production costs are not reduced.

By prioritizing individualized care, we recognize the value of every patient’s life and well-being, rather than forcing people to adapt to a one-size-fits-all solution. Ultimately, this approach could extend beyond heart valves, inspiring new standards across medicine where treatments adapt to patients, rather than patients adapting to treatments, making healthcare more precise and effective. It moves medicine beyond making the patient fit the valve toward making the valve fit the patient, transforming both cardiac surgery and the future of patient-centered care. 

As the next generation of scientists, engineers, and healthcare professionals, students today could play a direct role in solving these issues in the future, whether by developing more affordable materials, improving 3D printing technology, or shaping policies that ensure equitable access to life-saving treatments. Innovations such as patient-specific heart valves show how subjects studied in school, from biology to engineering, can translate into real-world solutions that save lives, making the future of medicine something students are not just learning about but actively building.